Literature DB >> 18062926

Identification of a novel human MT5-MMP transcript variant in multipotent NT2 cells.

Heather H Ross1, Helen L Fillmore.   

Abstract

Membrane-type 5 matrix metalloproteinase (MT5-MMP) expression is ubiquitous in brain development while restricted to regions of neuroplasticity in adult. In the multipotent NT2 model of neurogenesis and differentiation, MT5-MMP is differentially expressed with significantly higher mRNA levels in the differentiated neuronal hNT cells. MT5-MMP cDNA cloned from NT2 cells unexpectedly revealed a novel sequence (MT5-MMPvar) characterized by a 162bp deletion. Both transcripts were identified in NT2, hNT and adult human hippocampus. In vitro, MT5-MMPvar translated into a approximately 55 kDa protein. It was also detected in NT2, hNT and adult human hippocampus. These results suggest more than one human MT5-MMP transcript may exist in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18062926     DOI: 10.1016/j.febslet.2007.11.074

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Bromodeoxyuridine induces senescence in neural stem and progenitor cells.

Authors:  Heather H Ross; Lindsay H Levkoff; Gregory P Marshall; Maria Caldeira; Dennis A Steindler; Brent A Reynolds; Eric D Laywell
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

2.  In vivo intermittent hypoxia elicits enhanced expansion and neuronal differentiation in cultured neural progenitors.

Authors:  Heather H Ross; Milap S Sandhu; Tina F Cheung; Garrett M Fitzpatrick; Warren J Sher; Alexander J Tiemeier; Eric D Laywell; David D Fuller
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

3.  Expression of the orphan cytosolic sulfotransferase SULT4A1 and its major splice variant in human tissues and cells: dimerization, degradation and polyubiquitination.

Authors:  Neelima P Sidharthan; Neville J Butcher; Deanne J Mitchell; Rodney F Minchin
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.